HALO Growth 100 · Sector S2
Longevity & Healthspan
GLP-1 leaders, gene-editing platforms, diagnostics-at-scale, biopharma compounders. Demographics writes the demand curve.
Equal-weight — 1d —
Cap-weighted — 1d —
Momentum (drift) — 1d —
Constituents — in this sector
Composite Index — since inception (Dec 30, 2025)
Three weighting variants of the same constituent basket, rebased to 1,000 at inception. EW = ticker-equal-weight with quarterly drift. CW = cap-weighted (10% cap; below ten names the cap is infeasible, so the sub-index is equal weight by construction) with semi-annual rebalance. MW = drift-only (1/N at inception, market does the tilting between rebalances). Click a legend entry to toggle its line.
Constituents
Every HALO 100 constituent tagged into this sector. Click a column header to sort (best to worst). Click a row to open the stock detail page in a new tab.
| Ticker | Company | Region | Last | 1d | 1w | 1m | 3m | 6m | 1y | CCY |
|---|---|---|---|---|---|---|---|---|---|---|
| ILMN | Illumina | NAM | 273.04 | +2.75% | +1.13% | +28.04% | +40.50% | +114.35% | +167.01% | USD |
| NTRA | Natera | NAM | 410.35 | +0.46% | -0.54% | +26.20% | +44.59% | +97.30% | +153.91% | USD |
| GXI.DE | Gerresheimer | EUR | 27.52 | -0.72% | +5.68% | -1.22% | -5.36% | +56.54% | -27.50% | EUR |
| LLY | Eli Lilly | NAM | 1142.85 | -0.61% | -3.43% | -1.49% | -4.77% | +22.15% | +38.89% | USD |
| AMGN | Amgen | NAM | 403.04 | -1.04% | -2.79% | -8.99% | +9.99% | +15.84% | +36.93% | USD |
| VRTX | Vertex Pharma | NAM | 504.73 | -0.40% | -4.08% | -9.34% | -4.69% | +15.05% | +24.87% | USD |
| VKTX | Viking Therapeutics | NAM | 29.94 | -1.87% | -15.80% | -10.63% | -22.66% | -13.97% | +9.39% | USD |
| REGN | Regeneron | NAM | 735.20 | +0.05% | -6.71% | -13.71% | +13.14% | -3.50% | +22.85% | USD |
| ZEAL.CO | Zealand Pharma | EUR | 265.90 | +4.48% | -2.49% | -14.36% | -11.84% | -9.86% | -41.75% | DKK |
| NVO | Novo Nordisk | EUR | 37.32 | -0.21% | -3.81% | -20.21% | -24.24% | +0.92% | -34.61% | USD |